Knight Therapeutics, Inc. (GUD.TO)
9.75
+0.09
(+0.93%)
CAD |
TSX |
Aug 25, 16:00
Knight Therapeutics Total Liabilities (Quarterly) : 246.25M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 246.25M |
| March 31, 2026 | 299.33M |
| December 31, 2025 | 279.03M |
| September 30, 2025 | 281.78M |
| June 30, 2025 | 274.89M |
| March 31, 2025 | 207.60M |
| December 31, 2024 | 168.69M |
| September 30, 2024 | 188.38M |
| June 30, 2024 | 182.56M |
| March 31, 2024 | 206.32M |
| December 31, 2023 | 198.62M |
| September 30, 2023 | 196.48M |
| June 30, 2023 | 206.54M |
| March 31, 2023 | 225.90M |
| December 31, 2022 | 228.98M |
| September 30, 2022 | 180.83M |
| June 30, 2022 | 171.44M |
| March 31, 2022 | 165.84M |
| December 31, 2021 | 149.87M |
| September 30, 2021 | 165.02M |
| June 30, 2021 | 154.21M |
| March 31, 2021 | 171.32M |
| December 31, 2020 | 153.44M |
| September 30, 2020 | 131.74M |
| June 30, 2020 | 345.75M |
| Date | Value |
|---|---|
| March 31, 2020 | 390.77M |
| December 31, 2019 | 390.20M |
| September 30, 2019 | 64.08M |
| June 30, 2019 | 26.25M |
| March 31, 2019 | 25.64M |
| December 31, 2018 | 21.80M |
| September 30, 2018 | 21.00M |
| June 30, 2018 | 15.82M |
| March 31, 2018 | 15.37M |
| December 31, 2017 | 14.78M |
| September 30, 2017 | 13.02M |
| June 30, 2017 | 11.80M |
| March 31, 2017 | 10.10M |
| December 31, 2016 | 11.05M |
| September 30, 2016 | 8.305M |
| June 30, 2016 | 6.034M |
| March 31, 2016 | 5.663M |
| December 31, 2015 | 6.926M |
| September 30, 2015 | 2.372M |
| June 30, 2015 | 3.797M |
| March 31, 2015 | 5.973M |
| December 31, 2014 | 7.622M |
| September 30, 2014 | 1.036M |
| June 30, 2014 | 1.768M |
| March 31, 2014 | 2.990M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 104.01M |
| Bausch Health Cos., Inc. | 36.31B |
| Cipher Pharmaceuticals, Inc. | 27.86M |
| BioSyent, Inc. | 14.62M |
| Revive Therapeutics Ltd. | 4.306M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.045B |
| Shareholders Equity (Quarterly) | 798.59M |
| Debt to Equity Ratio | 0.0429 |
| Current Ratio | 2.280 |
| Net Debt Paydown Yield | 0.41% |